- Title
- Development of a high pressure liquid chromatographic method for the simultaneous analysis of sulphamethoxazole and trimethoprim and its application to biological fluids and dissolution rate studies on solid oral dosage forms
- Creator
- Gochin, Rosa
- ThesisAdvisor
- Kanfer, I
- ThesisAdvisor
- Haigh, J M
- Subject
- High performance liquid chromatography
- Subject
- Body fluids -- Analysis
- Subject
- Drugs -- Dosage forms
- Date
- 1980
- Type
- Thesis
- Type
- Masters
- Type
- MSc
- Identifier
- vital:3735
- Identifier
- http://hdl.handle.net/10962/d1001524
- Description
- Co-trimoxazole, a combination of a 5-to-l ratio of Sulphamethoxazole (SMZ) and Trimethoprim (TMP) , is a highly effective, broad-spectrum antibacterial agent. Since its introduction in 1968, it has been extensively used in infections of the respiratory and urinary tracts. Co-trimoxazole was developed by the systematic investigation of a series of compounds whose mechanism of action was already known. As early as 1950 synergy between sulphonamides and 2,4-diaminopyrimidines was reported. This was to be expected as both groups of drugs exert their antibacterial activity by interfering with the same biochemical pathway in bacteria. TMP was chosen from among many 2,4-diaminopyrimidines tested because of its good antibacterial activity and low toxicity. SMZ was chosen from the sulphonamides available for combination with TMP because of similarity of their biological half-lives. The widespread use of the combination coupled with the fact that monitoring of the levels of all drugs in the body is becoming increasingly important has stimulated research into rapid and efficient methods for the analysis of TMP and SMZ in biological fluids. Another consequence of the immense popularity of the combination is the appearance on the market of several generic preparations of Co-trimoxazole. It is now generally recognized that drug products from different manufacturers which are chemically equivalent may not be therapeutically equivalent. This is due to the fact that the absorption rate and/or bioavailability (extent of absorption) of a poorly soluble drug may be markedly affected by its release rate from the product and by its subsequent dissolution rate in gastrointestinal fluids. Hence bioequivalence of these various products should be established
- Format
- 226 leaves, pdf
- Publisher
- Rhodes University, Faculty of Science, Pharmacy
- Language
- English
- Rights
- Gochin, Rosa
- Hits: 1449
- Visitors: 1604
- Downloads: 169
Collections
RU Department of Pharmacy
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details | SOURCEPDF | 20 MB | Adobe Acrobat PDF | View Details |